Wegovy received UK marketing authorisation in 2023, and NICE guidance (TA875) supports its use within the NHS for adults with a BMI of at least 35 kg/m (or 30 kg/m with weight-related comorbidities), when provided through specialist weight management services, and for a maximum duration of 2 years
As a result, the drug conjugate showed efficacy in the treatment of glioblastoma compared with the free drug in our intracranial HIFko glioma model [93]
Weight-Loss Care Trends: Certifications, Mental Health, and the Push for Oral GLP-1s: Certifications: Despite 81% reporting prescribing any medications for weight loss or a weight loss benefit in the past year, 67% of those surveyed report not having any Obesity Treatment Certification, such as the American Board of Obesity Medicine or European Association Study of Obesity Medicine
Supporters cited a larger international literature than for several other peptides, while FDA staff said the material it could evaluate remained insufficient for the proposed uses
Should I take glutathione if I am already taking Vitamin C